🎉 M&A multiples are live!
Check it out!

Sanofi India Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sanofi India and similar public comparables like Julphar, Vivoryon Therapeutics, and Benevolent AI.

Sanofi India Overview

About Sanofi India

Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth.


Founded

1956

HQ

India
Employees

2.2K+

Financials

LTM Revenue $238M

LTM EBITDA $58.7M

EV

$1.6B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Sanofi India Financials

Sanofi India has a last 12-month revenue of $238M and a last 12-month EBITDA of $58.7M.

In the most recent fiscal year, Sanofi India achieved revenue of $234M and an EBITDA of $54.7M.

Sanofi India expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Sanofi India valuation multiples based on analyst estimates

Sanofi India P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $327M $234M XXX XXX XXX
Gross Profit $172M $181M XXX XXX XXX
Gross Margin 53% 77% XXX XXX XXX
EBITDA $103M $54.7M XXX XXX XXX
EBITDA Margin 31% 23% XXX XXX XXX
Net Profit $72.1M $70.0M XXX XXX XXX
Net Margin 22% 30% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Sanofi India Stock Performance

As of April 15, 2025, Sanofi India's stock price is INR 6185 (or $72).

Sanofi India has current market cap of INR 142B (or $1.7B), and EV of INR 139B (or $1.6B).

See Sanofi India trading valuation data

Sanofi India Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.6B $1.7B XXX XXX XXX XXX $1.80

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Sanofi India Valuation Multiples

As of April 15, 2025, Sanofi India has market cap of $1.7B and EV of $1.6B.

Sanofi India's trades at 6.8x LTM EV/Revenue multiple, and 27.5x LTM EBITDA.

Analysts estimate Sanofi India's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Sanofi India and 10K+ public comps

Sanofi India Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.6B XXX XXX XXX
EV/Revenue 6.9x XXX XXX XXX
EV/EBITDA 29.6x XXX XXX XXX
P/E 34.5x XXX XXX XXX
P/E/Growth 7.3x XXX XXX XXX
EV/FCF 32.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Sanofi India Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Sanofi India Valuation Multiples

Sanofi India's NTM/LTM revenue growth is 7%

Sanofi India's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $31K for the same period.

Over next 12 months, Sanofi India's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Sanofi India's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Sanofi India and other 10K+ public comps

Sanofi India Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -29% XXX XXX XXX XXX
EBITDA Margin 23% XXX XXX XXX XXX
EBITDA Growth -47% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 30% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $31K XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 29% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Sanofi India Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Nutraceuticals & Cosmeceuticals comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Sanofi India M&A and Investment Activity

Sanofi India acquired  XXX companies to date.

Last acquisition by Sanofi India was  XXXXXXXX, XXXXX XXXXX XXXXXX . Sanofi India acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Sanofi India

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Sanofi India

When was Sanofi India founded? Sanofi India was founded in 1956.
Where is Sanofi India headquartered? Sanofi India is headquartered in India.
How many employees does Sanofi India have? As of today, Sanofi India has 2.2K+ employees.
Is Sanofi India publicy listed? Yes, Sanofi India is a public company listed on BOM.
What is the stock symbol of Sanofi India? Sanofi India trades under 500674 ticker.
When did Sanofi India go public? Sanofi India went public in 1991.
Who are competitors of Sanofi India? Similar companies to Sanofi India include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Sanofi India? Sanofi India's current market cap is $1.7B
What is the current revenue of Sanofi India? Sanofi India's last 12-month revenue is $238M.
What is the current EBITDA of Sanofi India? Sanofi India's last 12-month EBITDA is $58.7M.
What is the current EV/Revenue multiple of Sanofi India? Current revenue multiple of Sanofi India is 6.8x.
What is the current EV/EBITDA multiple of Sanofi India? Current EBITDA multiple of Sanofi India is 27.5x.
What is the current revenue growth of Sanofi India? Sanofi India revenue growth between 2023 and 2024 was -29%.
Is Sanofi India profitable? Yes, Sanofi India is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.